Snapdragon IRIS Photoreactors Featured in Specialty Chemicals Magazine Case Study
Waltham, MA – November 8, 2021 – Snapdragon Chemistry’s innovative IRIS photoreactor platform and recent successful cGMP photochemistry scale-up were recently featured in a case study presented by Eric Fang, Chief Scientific Officer, in Specialty Chemicals Magazine (Nov/Dec 2021, page 58). As stated in the article, Snapdragon continues to invest in and develop new technologies in the promising field of photochemistry.
“Earlier this year, Snapdragon completed a groundbreaking photochemistry campaign for cGMP API manufacturing, making nearly 18 kg of the product with a single 5 kW Iris Max photoreactor. Making this drug for the first time in this quantity is extremely enabling and will help provide the proof many clients need to see photochemistry as efficient reliable and powerful.”
Read the full case study at the link below.
About Snapdragon Chemistry
Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff. For more information, please contact firstname.lastname@example.org.